Nan Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nan Hu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Changshun Ruan
Research Center for Human Tissue and Organ Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China
2 shared publications Baochun Guo
Department of Nephrology, Shenzhen People's Hospital, Shenzhen, R.P. China
1 shared publicationDuo Li
Research Center for Human Tissue and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, R.P. China
1 shared publication- Fan Yang
Guangdong Provincial Key Laboratory of Brain Connectome and Behavior, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
1 shared publication - Jie Shao
Department of Nephrology, The Second Clinical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China
1 shared publication Jinfeng Wang
Chongqing University, Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China, Chongqing, Chongqing, 400044, CHINA
1 shared publication
Latest Publications
- 12 February 2026
- Published by IOP Publishing in Biofabrication
- Vol. 18 (1) , 015037
The degradation behavior of 3D-printed polyurethane composite scaffolds regulates bone regeneration
Biodegradable scaffolds offer a promising platform for in situ bone regeneration, yet the regulatory mechanism underlying how the degradation behavior of the scaffold influences bone regeneration is still unclear. Herein, by harnessing β -tricalcium phosphate ( β -TCP) as a dual regulator for degradation and osteogenesis, a series of degradation-tunable polyurethane biodegradable polyurethane/ β -TCP composite scaffolds (PT scaffolds) was developed as the ideal foundation to explore the regulatory role of degradation behavior in bone regeneration. The PT scaffolds fabricated via a low-temperature deposition three-dimensional printing, presented a porous structure with interconnected macro-pores and abundant micro-pores, superior mechanical properties, and excellent osteogenic capability. Both in vitro and in vivo degradation-tunable behaviors of these PT scaffolds were comprehensively investigated. By adjusting β -TCP contents, their degradation half-life could be tuned from 10.5 to 16.7 weeks in vitro and from 11.2 to 17.7 weeks in vivo , with their average degradation rates ranging from 9.9%/week to 5.3%/week in vitro and 9.5%/week to 3.8%/week in vivo . By implantation into two different bone defect models, the PT scaffold, whose degradation behavior is synchronous with the bone regeneration process, was observed to yield better bone formation, suggesting that the degradation behavior of scaffolds itself is of great importance in determining the bone regeneration.
- 12 February 2026
- Published by IOP Publishing in Biofabrication
- Vol. 18 (1) , 015037
The degradation behavior of 3D-printed polyurethane composite scaffolds regulates bone regeneration
Biodegradable scaffolds offer a promising platform for in situ bone regeneration, yet the regulatory mechanism underlying how the degradation behavior of the scaffold influences bone regeneration is still unclear. Herein, by harnessing β -tricalcium phosphate ( β -TCP) as a dual regulator for degradation and osteogenesis, a series of degradation-tunable polyurethane biodegradable polyurethane/ β -TCP composite scaffolds (PT scaffolds) was developed as the ideal foundation to explore the regulatory role of degradation behavior in bone regeneration. The PT scaffolds fabricated via a low-temperature deposition three-dimensional printing, presented a porous structure with interconnected macro-pores and abundant micro-pores, superior mechanical properties, and excellent osteogenic capability. Both in vitro and in vivo degradation-tunable behaviors of these PT scaffolds were comprehensively investigated. By adjusting β -TCP contents, their degradation half-life could be tuned from 10.5 to 16.7 weeks in vitro and from 11.2 to 17.7 weeks in vivo , with their average degradation rates ranging from 9.9%/week to 5.3%/week in vitro and 9.5%/week to 3.8%/week in vivo . By implantation into two different bone defect models, the PT scaffold, whose degradation behavior is synchronous with the bone regeneration process, was observed to yield better bone formation, suggesting that the degradation behavior of scaffolds itself is of great importance in determining the bone regeneration.
- Open Access
- 4 September 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 166, 115422
New insights into the mechanisms of diabetic kidney disease: Role of circadian rhythm and Bmal1
- 4 September 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 166, 115422
Open AccessNew insights into the mechanisms of diabetic kidney disease: Role of circadian rhythm and Bmal1
- 8 June 2020
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 14 (10) , 1363-1377
Tissue‐engineered parathyroid gland and its regulatory secretion of parathyroid hormone
Parathyroid glands (PTGs) are important endocrine organs being mainly responsible for the secretion of parathyroid hormone (PTH) to regulate the balance of calcium (Ca) /phosphorus (P) ions in the body. Once PTGs get injured or removed, their resulting defect or loss of PTH secretion should disturb the level of Ca/P in blood, thus damaging other related organs (bone, kidney, etc.) and even causing death. Recently, tissue‐engineered PTGs (TE‐PTGs) have attracted lots of attention as a potential treatment for the related diseases of PTGs caused by hypoparathyroidism and hyperparathyroidism, including tetany, muscle cramp, nephrolithiasis, nephrocalcinosis as well as osteoporosis. Although great progress has been made in the establishment of TE‐PTGs with an effective strategy to integrate the key factors of cells and biomaterials, its regulatory secretion of PTH to mimic its natural rhythms in the body remains a huge challenge. This review comprehensively describes an overview of PTGs from physiology and pathology to cytobiology and tissue engineering. The state of the arts in TE‐PTGs and the feasible strategies to regulate PTH secretion behaviors are highlighted to provide an important foundation for further investigation.
- 8 June 2020
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 14 (10) , 1363-1377
Tissue‐engineered parathyroid gland and its regulatory secretion of parathyroid hormone
Parathyroid glands (PTGs) are important endocrine organs being mainly responsible for the secretion of parathyroid hormone (PTH) to regulate the balance of calcium (Ca) /phosphorus (P) ions in the body. Once PTGs get injured or removed, their resulting defect or loss of PTH secretion should disturb the level of Ca/P in blood, thus damaging other related organs (bone, kidney, etc.) and even causing death. Recently, tissue‐engineered PTGs (TE‐PTGs) have attracted lots of attention as a potential treatment for the related diseases of PTGs caused by hypoparathyroidism and hyperparathyroidism, including tetany, muscle cramp, nephrolithiasis, nephrocalcinosis as well as osteoporosis. Although great progress has been made in the establishment of TE‐PTGs with an effective strategy to integrate the key factors of cells and biomaterials, its regulatory secretion of PTH to mimic its natural rhythms in the body remains a huge challenge. This review comprehensively describes an overview of PTGs from physiology and pathology to cytobiology and tissue engineering. The state of the arts in TE‐PTGs and the feasible strategies to regulate PTH secretion behaviors are highlighted to provide an important foundation for further investigation.